Orforglipron represents the next evolution in this space as a highly effective, non-peptide oral GLP-1 receptor agonist
Kushner, M.D., Ildiko Lingvay, M.D., M.P.H., Tugce K
When to adjust your protocol Knowing when and how to modify your approach separates successful protocols from those that plateau or fail
MASH, formerly known as NASH, is a further area of pipeline intensity
Graphic Abstract Our results clearly showed that LPS increased the cellular ROS by recognizing the TLR4 and H 2 O 2 rapidly increased the cellular (1) and mitochondrial (2) oxidative stress
This could be due to the differences in ethnicity of participants